Sign up
Pharma Capital
EPIC: LLP
Market: CSE
52-week High/Low: C$0.12 / C$0.03
Sector: Pharma & Biotech
Market Cap: C$3.81M

LeanLife has developed a patented process to isolate omega-3 fatty acids from flax (linen) seeds. LeenLife omega products are in the form of an oil or a powder with a purity in excess of 98%. The products are sold on-line or as a food additive to food processors making such items as bread, noodles and milk products.

LeanLife Health

leenlifepharma.com

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in LeanLife Health

LeanLife Health Snapshot

Stan Lis
Chief Executive Officer

Mr. Lis was the co‐founder, past president and director of MicroCoal Technologies Inc. (formerly Carbon Friendly Solutions Inc.) from its inception in 2006 to 2015. From 2000 until 2006, he was the president, CEO and director of Stream Communications Network & Media Inc., a cable company where he was directly responsible for taking the company from start up to 65,000 subscribers. From 1993 until 2000, Mr. Lis acted as President, CEO and director of Trooper Technologies Inc., an environmental company focused on waste management in Central Europe. In 1988 he founded International UNP Holdings Ltd., a Toronto Stock Exchange Investment Company used to acquire and finance privatized Polish state enterprises. Mr. Lis studied Business Administration and Securities at Simon Fraser University. Mr. Lis personally raised over $60 million to finance the above mentioned companies.

 

Carl F. Perez, PhD
Chief Technical Officer

Dr. Perez has more than 30 years of leadership in academic research programs and has experience in all phases of drug discovery, process development, preclinical development, FDA/Health Canada regulatory compliance, and cGMP manufacturing. Dr. Perez was Director Preclinical Programs for Chromos Molecular Systems (Burnaby, BC) and VP Product Development for Metaara Medical Technologies (Vancouver, BC).

 

Marcin Łukaszewicz, PhD

Dr. Łukaszewicz is the Dean of the Department of Biotransformation, at the Faculty of Biotechnology, University of Wroclaw (Poland). Dr. Łukaszewicz is an expert in molecular biology, biotechnology, and microbiology.

 

Michael G. Wystrach, USMC (retired), Director

Mr. Wystrach, has a background in developing and managing projects in real estate, food services, retail outlets, and technology companies. Mr. Wystrach brings commercial experience and expertise will significantly boost LeanLife’s efforts to enter the U.S. marketplace.

 

Brian Banducci, Director

Mr. Banducci has owned and operated BWF Banducci Inc. (California) for 11 years and Banducci México S.A. de C.V. Mazatlán, Mexico for 8 years. Mr. Banducci brings a wealth of knowledge and experience in identifying, evaluating, certifying and bringing to market organic products from all over the world, which in turn will benefit LeanLife’s efforts to enter the U.S. marketplace.

 

Glen Macdonald, Director

Mr. MacDonald is a self-employed geology consultant. Mr. Macdonald has served as CEO, President, and Director for numerous private and public companies with particular expertise in corporate development and fiduciary compliance.

 

Jason Tong, Financial Chief

 

 

 

 

 

 

LeenLife Pharma International Inc.

Suite 380 – 580 Hornby Street
Vancouver, BC  V6C 3B6

Phone: +1 604-764-0518.

View full LLP profile View Profile
Newswire

LeanLife issues stock options

View All

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.